Works matching AU Kato, J.

Results: 232
    1
    2
    3
    4
    5

    Japan.

    Published in:
    European Journal of Political Research, 2003, v. 42, n. 7/8, p. 996, doi. 10.1111/j.0304-4130.2003.00126.x
    By:
    • Kato, J.
    Publication type:
    Article
    6

    Japan.

    Published in:
    European Journal of Political Research, 2002, v. 41, n. 7/8, p. 1001, doi. 10.1111/1475-6765.00055
    By:
    • Kato, J.
    Publication type:
    Article
    7
    8
    9
    10
    11

    Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.

    Published in:
    Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 727, doi. 10.1038/bmt.2015.17
    By:
    • Tanaka, M;
    • Kanamori, H;
    • Matsumoto, K;
    • Tachibana, T;
    • Numata, A;
    • Ohashi, K;
    • Kobayashi, T;
    • Nakaseko, C;
    • Kanda, Y;
    • Yamazaki, E;
    • Fujisawa, S;
    • Ooi, J;
    • Sakura, T;
    • Aotsuka, N;
    • Onoda, M;
    • Machida, S;
    • Kato, J;
    • Usuki, K;
    • Watanabe, R;
    • Taguchi, J
    Publication type:
    Article
    12
    13
    14
    15

    Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.

    Published in:
    Bone Marrow Transplantation, 2008, v. 42, n. 3, p. 197, doi. 10.1038/bmt.2008.152
    By:
    • Mori, T.;
    • Watanabe, M.;
    • Kurotori-Sotome, T.;
    • Ito, C.;
    • Yamada, K.;
    • Yashima, T.;
    • Kobayashi, N.;
    • Kondo, S.;
    • Aisa, Y.;
    • Kato, J.;
    • Ogawa, Y.;
    • Tsubota, K.;
    • Shigematsu, N.;
    • Kubo, A.;
    • Ikeda, Y.;
    • Okamoto, S.
    Publication type:
    Article
    16

    Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.

    Published in:
    Bone Marrow Transplantation, 2007, v. 39, n. 4, p. 217, doi. 10.1038/sj.bmt.1705578
    By:
    • Mori, T.;
    • Aisa, Y.;
    • Yokoyama, A.;
    • Nakazato, T.;
    • Yamazaki, R.;
    • Shimizu, T.;
    • Mihara, A.;
    • Kato, J.;
    • Watanabe, R.;
    • Takayama, N.;
    • Ikeda, Y.;
    • Okamoto, S.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Liver injury is associated with mortality in sickle cell disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 7, p. 912, doi. 10.1111/apt.13347
    By:
    • Feld, J. J.;
    • Kato, G. J.;
    • Koh, C.;
    • Shields, T.;
    • Hildesheim, M.;
    • Kleiner, D. E.;
    • Taylor, J. G.;
    • Sandler, N. G.;
    • Douek, D.;
    • Haynes‐Williams, V.;
    • Nichols, J. S.;
    • Hoofnagle, J. H.;
    • Jake Liang, T.;
    • Gladwin, M. T.;
    • Heller, T.
    Publication type:
    Article
    34
    35
    36

    Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom.

    Published in:
    PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0099489
    By:
    • Gladwin, Mark T.;
    • Barst, Robyn J.;
    • Gibbs, J. Simon R.;
    • Hildesheim, Mariana;
    • Sachdev, Vandana;
    • Nouraie, Mehdi;
    • Hassell, Kathryn L.;
    • Little, Jane A.;
    • Schraufnagel, Dean E.;
    • Krishnamurti, Lakshmanan;
    • Novelli, Enrico;
    • Girgis, Reda E.;
    • Morris, Claudia R.;
    • Berman Rosenzweig, Erika;
    • Badesch, David B.;
    • Lanzkron, Sophie;
    • Castro, Oswaldo L.;
    • Taylor VI, James G.;
    • Goldsmith, Jonathan C.;
    • Kato, Gregory J.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure–activity relationship comparative study with triazole‐neolignan‐based compounds.

    Published in:
    Chemical Biology & Drug Design, 2019, v. 94, n. 6, p. 2004, doi. 10.1111/cbdd.13609
    By:
    • Neves, Amarith R.;
    • Trefzger, Ozildéia S.;
    • Barbosa, Natália V.;
    • Honorato, Antonio M.;
    • Carvalho, Diego B.;
    • Moslaves, Iluska S.;
    • Kadri, Mônica C. T.;
    • Yoshida, Nidia C.;
    • Kato, Massuo J.;
    • Arruda, Carla C. P.;
    • Baroni, Adriano C. M.
    Publication type:
    Article
    43

    Design, synthesis and antitrypanosomatid activities of 3,5‐diaryl‐isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.

    Published in:
    Chemical Biology & Drug Design, 2019, v. 93, n. 3, p. 313, doi. 10.1111/cbdd.13417
    By:
    • Trefzger, Ozildéia S.;
    • das Neves, Amarith R.;
    • Barbosa, Natália V.;
    • Carvalho, Diego B.;
    • Pereira, Indiara C.;
    • Perdomo, Renata T.;
    • Matos, Maria F. C.;
    • Yoshida, Nidia C.;
    • Kato, Massuo J.;
    • Albuquerque, Sérgio;
    • Arruda, Carla C. P.;
    • Baroni, Adriano C. M.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Leg Ulcers in Sickle Cell Disease: Current Patterns and Practices.

    Published in:
    Hemoglobin, 2013, v. 37, n. 4, p. 325, doi. 10.3109/03630269.2013.789968
    By:
    • Delaney, Kara-Marie H.;
    • Axelrod, Karen C.;
    • Buscetta, Ashley;
    • Hassell, Kathryn L.;
    • Adams-Graves, Patricia E.;
    • Seamon, Catherine;
    • Kato, Gregory J.;
    • Minniti, Caterina P.
    Publication type:
    Article
    50